Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

Share Price is delayed by 15 minutes
Get Live Data
2,470.00    50.00 (2.07%)
Bid:
2,466.00
Ask:
2,470.00
Spread: 4.00 (0.162%)
Market Cap: £7.93b
BNZL Live PriceLast checked at - London Stock Exchange

Intraday Bunzl Share Chart

Acquisition

23 Nov 2017 07:00

RNS Number : 2712X
Bunzl PLC
23 November 2017
 

23 November 2017

 

 

BUNZL COMPLETES ACQUISTION IN FRANCE AND ANNOUNCES FURTHER EXPANSION IN AUSTRALIA AND BRAZIL

 

Bunzl plc, the international distribution and outsourcing Group, today announces that the acquisition of Hedis, Comptoir de Bretagne and Générale Collectivités, that was announced on 20 July 2017, has been completed following clearance of the transaction by the French Competition Authority.

 

The Company has also recently acquired Interpath in Australia and entered into an agreement to acquire Talge in Brazil.

 

Interpath, which is based in Melbourne, is principally engaged in the distribution of a variety of laboratory and healthcare related consumable products to the pathology, medical research and life science end user markets in Australia. Customers include public and private hospitals and other pathology and research laboratories. Revenue in the year ended June 2017 was A$22 million (c.£13 million).

 

Talge, which is based in Santa Catarina, is principally engaged in the sale of a variety of foodservice related products, mainly to redistributors in the southeast region of Brazil. Revenue in the year ended December 2016 was R$83 million (c.£20 million). Completion of the acquisition is subject to clearance of the transaction by the Brazilian competition authority.

 

Commenting on the acquisitions, Frank van Zanten, Chief Executive of Bunzl said:

 

"I am delighted that we have now completed the purchase of Hedis, Comptoir de Bretagne and Générale Collectivités. Together these businesses further expand our existing cleaning & hygiene operations in France and extend our business there into the catering equipment sector for the first time.

 

The acquisition of Interpath has enhanced our healthcare business in Australia and extended our product offering into the pathology, medical research and life science markets there, while the proposed purchase of Talge will expand our operations into the foodservice sector in Brazil."

 

 

Enquiries:

 

Bunzl plc

Frank van Zanten, Chief Executive

Brian May, Finance Director

Tel: 020 7725 5000

Tulchan

David Allchurch

Martin Robinson

Tel: 020 7353 4200

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQBTBATMBTTBTR
Date   Source Headline
21st Nov 20247:00 amRNSTransaction in Own Shares
20th Nov 20247:00 amRNSTransaction in Own Shares
19th Nov 20247:00 amRNSTransaction in Own Shares
18th Nov 20247:00 amRNSTransaction in Own Shares
15th Nov 20247:00 amRNSTransaction in Own Shares
14th Nov 20247:00 amRNSPublication of Admission Particulars
14th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 20247:00 amRNSTransaction in Own Shares
11th Nov 20247:00 amRNSTransaction in Own Shares
8th Nov 20247:00 amRNSTransaction in Own Shares
7th Nov 20247:00 amRNSTransaction in Own Shares
6th Nov 202412:21 pmRNSHolding(s) in Company
6th Nov 202410:18 amRNSDirector/PDMR Shareholding
6th Nov 20247:00 amRNSTransaction in Own Shares
5th Nov 202411:22 amRNSHolding(s) in Company
5th Nov 20247:00 amRNSTransaction in Own Shares
4th Nov 20247:00 amRNSTransaction in Own Shares
1st Nov 20242:29 pmRNSBlock listing Interim Review
1st Nov 20241:42 pmRNSTotal Voting Rights
1st Nov 20247:00 amRNSTransaction in Own Shares
31st Oct 20247:00 amRNSTransaction in Own Shares
30th Oct 20247:00 amRNSTransaction in Own Shares
29th Oct 20247:00 amRNSTransaction in Own Shares
28th Oct 20244:20 pmRNSDirector/PDMR Shareholding
28th Oct 20247:00 amRNSTransaction in Own Shares
25th Oct 20247:00 amRNSTransaction in Own Shares
24th Oct 20247:00 amRNSTransaction in Own Shares
24th Oct 20247:00 amRNSTrading Statement
23rd Oct 20247:00 amRNSTransaction in Own Shares
22nd Oct 20247:00 amRNSTransaction in Own Shares
21st Oct 20247:00 amRNSTransaction in Own Shares
18th Oct 20247:00 amRNSTransaction in Own Shares
17th Oct 20247:00 amRNSTransaction in Own Shares
16th Oct 20247:00 amRNSTransaction in Own Shares
15th Oct 20247:00 amRNSTransaction in Own Shares
14th Oct 20247:00 amRNSTransaction in Own Shares
11th Oct 20247:00 amRNSTransaction in Own Shares
10th Oct 20247:00 amRNSTransaction in Own Shares
9th Oct 20247:00 amRNSTransaction in Own Shares
8th Oct 20249:15 amRNSIssue of Debt
8th Oct 20247:00 amRNSTransaction in Own Shares
7th Oct 20247:00 amRNSTransaction in Own Shares
4th Oct 20247:00 amRNSTransaction in Own Shares
3rd Oct 20247:00 amRNSTransaction in Own Shares
2nd Oct 20245:10 pmRNSDirector/PDMR Shareholding
2nd Oct 20245:02 pmRNSDirector/PDMR Shareholding
2nd Oct 20247:00 amRNSTransaction in Own Shares
1st Oct 20242:38 pmRNSTotal Voting Rights
1st Oct 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.